Inhibition of E2F Abrogates the Development of Cardiac Myocyte Hypertrophy
Open Access
- 1 June 2003
- journal article
- Published by Elsevier
- Vol. 278 (24) , 21388-21394
- https://doi.org/10.1074/jbc.m212612200
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In VivoMolecular and Cellular Biology, 2002
- Sibling rivalry in the E2F familyNature Reviews Molecular Cell Biology, 2002
- Expressions and Activities of Cell Cycle Regulatory Molecules During the Transition from Myocyte Hyperplasia to HypertrophyJournal of Molecular and Cellular Cardiology, 1998
- Changes in E2F Complexes Containing Retinoblastoma Protein Family Members and Increased Cyclin-dependent Kinase Inhibitor Activities During Terminal Differentiation of CardiomyocytesJournal of Molecular and Cellular Cardiology, 1998
- Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.Journal of Clinical Investigation, 1997
- Role of the Rb/E2F pathway in cell growth controlJournal of Cellular Physiology, 1997
- Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factorNature Biotechnology, 1997
- Expression and Activities of Cyclins and Cyclin-dependent Kinases in Developing Rat Ventricular MyocytesJournal of Molecular and Cellular Cardiology, 1997
- Rapid Transition of Cardiac Myocytes from Hyperplasia to Hypertrophy During Postnatal DevelopmentJournal of Molecular and Cellular Cardiology, 1996
- The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factorNucleic Acids Research, 1990